Stephen Morlock, Director at BioPharmX Corp (BPMX), bought 5,000 shares at $1.47 ($7K) on 2016-01-07, disclosed to the SEC on 2016-01-11.
Open-market purchase of $7k BPMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BPMX | BUY | 2016-11-29 | $150K | — | Filing → |
| BPMX | BUY | 2016-01-15 | $18K | — | Filing → |
| BPMX | BUY | 2016-01-12 | $9K | — | Filing → |